In this CBS News Boston feature, Dotmatics® executives Kalim Saliba and Steve Tharp discuss the groundbreaking impact of artificial intelligence (AI) in advancing scientific research and development for pharmaceutical drug discovery. Watch as they discuss how Dotmatics is utilizing AI to revolutionize the field, bringing innovative solutions to complex challenges in the life sciences sector.
Watch this feature on CBS News Boston to discover more about our cutting-edge work in AI and its pivotal role in shaping the future of scientific discovery.
Learn More About Dotmatics
Meet with a product expert to see how Dotmatics uses AI technologies to drive down the cost of drug discovery.